Sort
30,917 grants matching “tumor microenvironment”
Innate Antiviral Signals for Cancer Immunotherapy
$390,425Matthias Gromeier · Duke University · R01 · FY2024 · NS
Multi-Scale Optical Imaging of the Cancer Vasculature and Tumor Microenvironment
$390,411Seok H Yun · Methodist Hospital Research Institute · U54 · FY2012 · CA
A vicious cycle of pyroptotic cancer cells and fibroblasts fuels chemoresistance
$390,397Keith Syson Chan · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Biased chemokine receptor signaling in cancer progression
$390,393Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2019 · CA
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$390,265John H Sampson · Duke University · P50 · FY2018 · CA
Aging and Leydig Cell Function
$390,228Barry R Zirkin · Johns Hopkins University · R37 · FY2014 · AG
Aging and Leydig Cell Function
$390,225Barry R Zirkin · Johns Hopkins University · R37 · FY2012 · AG
The Role of post-translational activation of Myc in pancreatic cancer
$390,191Rosalie C Sears · Oregon Health & Science University · R01 · FY2018 · CA
The Role of post-translational activation of Myc in pancreatic cancer
$390,191Rosalie C Sears · Oregon Health & Science University · R01 · FY2017 · CA
Develop RAMAN imaging to visualize metabolism in cell lines and tissue
$390,178Mioara Larion · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Lipids and Myeloid Cell Function in Cancer
$390,171Luis J. Montaner · Wistar Institute · R01 · FY2019 · CA
ADAM17 in pancreatic cancer and pancreatitis
$390,135Howard C Crawford · Mayo Clinic Jacksonville · R01 · FY2012 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$390,089Haian Fu · Emory University · P01 · FY2023 · CA
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
$390,087Mark L Day · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer
$390,080Don X Nguyen · Yale University · P50 · FY2021 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$390,077Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Regulation of collagen linearization during cancer progression and metastasis
$390,077Myriam Labelle · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$390,077Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancer
$390,063Zhihui Wang · Methodist Hospital Research Institute · R01 · FY2023 · CA
Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancer
$390,063Zhihui Wang · Methodist Hospital Research Institute · R01 · FY2022 · CA
Circadian interventions against glioblastoma
$390,062Erik Herzog · Washington University · R01 · FY2025 · NS
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$390,030Rebekah White · University Of California, San Diego · R01 · FY2025 · CA
Mechanisms of Synergistic Regulation of Stem/Progenitors
$390,000Hal E. Broxmeyer · Indiana University Indianapolis · R01 · FY2014 · HL
Cell Cycle Checkpoint that Monitors Morphogenesis
$390,000Daniel J Lew · Duke University · R01 · FY2009 · GM
Targeting TMPRSS2 expression as a therapy for coronavirus infection and replication
$390,000Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2020 · CA